FDA Drug Shortages — Page 2

1,660 drug shortages total

Browse FDA drug shortages by generic name, company, and status. RegDataLab tracks 1,660 drug shortages from official FDA sources, updated on an ongoing basis.

FDA Drug Shortages (page 2 of 34)

Drug shortages	Details
Bupivacaine Hydrochloride Injection	Current — Somerset Therapeutics, LLC
Podophyllum Resin Topical Tincture	To Be Discontinued — Padagis US LLC
Belladonna and Opium Suppository	To Be Discontinued — Padagis US LLC
Dexmedetomidine Hydrochloride Injection	Current — Somerset Therapeutics, LLC
Belladonna and Opium Suppository	To Be Discontinued — Padagis US LLC
Bupivacaine Hydrochloride Injection	Current — Aspiro Pharma Limited
Tobramycin Sulfate Injection	To Be Discontinued — Hospira, Inc., a Pfizer Company
Glycopyrrolate Injection	To Be Discontinued — Fresenius Kabi USA, LLC
Bupivacaine Hydrochloride Injection	Current — Somerset Therapeutics, LLC
Glycopyrrolate Injection	To Be Discontinued — Fresenius Kabi USA, LLC
Hydrocortisone Acetate Suppository	To Be Discontinued — Padagis US LLC
Bupivacaine Hydrochloride Injection	Current — Aspiro Pharma Limited
Ritonavir Tablet	To Be Discontinued — AbbVie Inc.
Travoprost Ophthalmic Solution	To Be Discontinued — Mylan Pharmaceuticals Inc., a Viatris Company
Travoprost Ophthalmic Solution	To Be Discontinued — Mylan Pharmaceuticals Inc., a Viatris Company
Desflurane Liquid for Inhalation	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Bupivacaine Hydrochloride Injection	Current — ONESOURCE SPECIALTY PTE LTD
Daptomycin Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Oxaliplatin Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Gadobutrol Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Daptomycin Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Gadobutrol Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Gadobutrol Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Caspofungin Acetate Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Caspofungin Acetate Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Bupivacaine Hydrochloride Injection	Current — Hospira, Inc., a Pfizer Company
Oxaliplatin Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Lisdexamfetamine Dimesylate Capsule	Current — Sun Pharmaceutical Industries, Inc.
Gadobutrol Injection	To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Ifosfamide Injection	Current — Hikma Pharmaceuticals USA, Inc.
Dexmedetomidine Hydrochloride Injection	Current — Azurity Pharmaceuticals, Inc
Dacomitinib Tablet	To Be Discontinued — Pfizer Inc.
Dacomitinib Tablet	To Be Discontinued — Pfizer Inc.
Ifosfamide Injection	Current — Baxter Healthcare
Ifosfamide Injection	Current — Baxter Healthcare
Dacomitinib Tablet	To Be Discontinued — Pfizer Inc.
Leflunomide Tablet	To Be Discontinued — Sanofi-Aventis U.S. LLC
Ifosfamide Injection	Current — Fresenius Kabi USA, LLC
Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release	To Be Discontinued — Amneal Pharmaceuticals
Dexmedetomidine Hydrochloride Injection	Current — Azurity Pharmaceuticals, Inc
Semaglutide Tablet	To Be Discontinued — Novo Nordisk, Inc.
Emtricitabine Capsule	To Be Discontinued — Gilead Sciences, Inc.
Semaglutide Tablet	To Be Discontinued — Novo Nordisk, Inc.
Ifosfamide Injection	Current — Hikma Pharmaceuticals USA, Inc.
Ifosfamide Injection	Current — Baxter Healthcare
Leflunomide Tablet	To Be Discontinued — Sanofi-Aventis U.S. LLC
Dexamethasone Sodium Phosphate Injection	Current — Fresenius Kabi USA, LLC
Dexmedetomidine Hydrochloride Injection	Current — Azurity Pharmaceuticals, Inc
Semaglutide Tablet	To Be Discontinued — Novo Nordisk, Inc.
Lorlatinib Tablet	To Be Discontinued — Pfizer Inc.